The FDA has granted breakthrough device designation for an implantable insulin pump designed for people with type 1 diabetes, ...
Oslo, Norway, 17 February 2026 – Oncoinvent, a biotech developing a receptor-independent alpha radiopharmaceutical to ...
Quantitative amplification ratio for established and emerging biomarkers in gastroesophageal (GE) cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This ...
Gastric cancer remains a formidable adversary, ranking as the fifth most common cancer and the third-leading cause of cancer-related deaths worldwide, with over 1,000,000 new cases and close to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results